NEW YORK (GenomeWeb News) – PerkinElmer has acquired NTD Laboratories and J.N. Macri Technologies for around $56.65 million, bringing the company closer to its goal of building a “screening and diagnostics capability in maternal health,” PerkinElmer said today.

Separately today, PerkinElmer said Texas has selected it to supply instruments and reagents for its enhanced newborn screening program.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.